Introduction {#s1}
============

Prions are infectious agents composed solely of proteins, whose replication does not rely upon the presence of nucleic acids [@pcbi.1000420-Prusiner1]. Although the molecular mechanisms of prion replication are poorly understood, the current working hypothesis is based on the assumption that prions replicate by means of an autocatalytic process which converts cellular prion protein () to the disease-associated misfolded PrP isoform (). This process of replication of a prion depends upon the capacity of the pathogenic protein form to bind to and to catalyze the conversion of existing intermediate molecules. Recent studies [@pcbi.1000420-Safar1] have observed that the prion protein can misfold into a range of different aggregated forms derived from a continuum of structural conformation templates [@pcbi.1000420-Legname1] from which different phenotypic and pathological states derive. The ability of the same encoded protein to encipher a multitude of phenotypic states is known as the "prion strain phenomenon" [@pcbi.1000420-Peretz1]. Prion strains are defined as infectious isolates that, when transmitted to identical hosts, exhibit the following distinct prion disease phenotypes:

1.  i) Proteinase K (PK) digestion profile;

2.  ii) Incubation time;

3.  iii) Histopathological lesion profiles;

4.  iv) Specific neuronal target areas.

A reason for the strain phenomenon can be the association of to several disease conformations, characterizable by means of a different stability against denaturation, different post-translational modifications (e.g. glycosylation) and distinct cleavage sites. These observations are reinforced by [@pcbi.1000420-Petkova1], where it is reported that the amyloid fibrils (formed by the 40-residues -amyloid peptide) with different morphologies have significantly different molecular structures. These differences are shown to be self-propagating and to be associated with different toxicities, suggesting the possibility for a structural origin of prion strains. Moreover, recent studies on prion disease have confirmed that the incubation time is related not only to the inoculum dosage and the prion protein expression, but also to the resistance of prion strains against denaturation [@pcbi.1000420-Legname1] in terms of the concentration of guanidine hydrochloride (Gdn-HCl) required to denaturate 50% of the disease-causing protein (see [Text S1](#pcbi.1000420.s003){ref-type="supplementary-material"} for further discussions). Other studies have highlighted a strong relationship between the stability of the prion protein against denaturation and neuropathological lesion profiles [@pcbi.1000420-Legname2],[@pcbi.1000420-Sigurdson1]. Lesions due to stable prions tend to show large vacuolations localized in specific small brain regions, whilst lesions due to unstable prion strains show a less intense vacuolation and are more widely distributed in the brain. Apart from these properties, crucial details of the molecular mechanisms enabling the characterization of different prion strains are still missing. For example, neither structural characterizations of , nor maps of protein-protein interactions have so far been provided, and even the biological function is unclear. Hence, in order to use the existing data to gain some insight into the properties of the different prion strains, we decided to follow a model-based approach.

In this paper, using a well established model for the kinetics of the in vivo prion replication [@pcbi.1000420-Masel1], we relate the evidence about conformational stability to the parameters of the model describing the evolution in time of the fibril length. The main points we deduce from our analysis are:

1.  i) In terms of the model, the key parameter describing strain-dependent replication kinetics is the fibril breakage rate.

2.  ii) A precise fitting of the model prediction to the experimental data is obtained assuming that also the aggregation rate changes with the strain. In particular, a functional dependence on the breakage rate is assumed.

3.  iii) The prediction of the model is that the stability against denaturation is inversely correlated to both breakage and aggregation rates and directly correlated with the mean length of fibrils.

4.  iv) By fitting experimental data, we can quantitatively predict the fibril length distributions associated to different prion strains.

Multiple experimental observations *in vitro* [@pcbi.1000420-Sun1] and in yeast [@pcbi.1000420-Tanaka1],[@pcbi.1000420-Kryndushkin1] support our model-based considerations, reinforcing our predictions for *in vivo* mammalian systems.

Results {#s2}
=======

Protein polymerization seems to have a central role in the progression of the prion pathology, an aspect shared with several other neurodegenerative diseases associated with different aggregating proteins, such as Alzheimer\'s (A ), Parkinson\'s (-synuclein) and Huntington\'s (huntingtin) diseases. The aggregation kinetics of amyloid peptides has been studied extensively (see [@pcbi.1000420-Morris1],[@pcbi.1000420-Pellarin1]), and has shed light on the wide range of amyloid aggregation mechanisms observed. Many modeling approaches have been introduced for this purpose in recent years, e.g. theoretical models consisting of nonlinear ordinary differential equations (ODEs), two-dimensional lattice-based statistical models and molecular dynamics simulations [@pcbi.1000420-Masel1], [@pcbi.1000420-Pellarin1]--[@pcbi.1000420-Eigen1]. In this paper we explore a mathematical description of the prion replication dynamics through nonlinear ODEs. This class of models explain the appearance of the disease by means of a bistability induced by a quadratic term, as in classical epidemic models [@pcbi.1000420-Nowak2]. The model we used is drawn from [@pcbi.1000420-Masel1],[@pcbi.1000420-Masel2] and is based on a nucleated polymerization mechanism [@pcbi.1000420-Jarrett1] (see [Materials and Methods](#s4){ref-type="sec"}). This approach has been shown to overcome the limitations of the "heterodimer model" [@pcbi.1000420-Prusiner1] and to be a reasonable simplification of the "cooperative autocatalysis" approach [@pcbi.1000420-Eigen1]. Furthermore, it is able to explain the kinetics of spontaneous generation [@pcbi.1000420-Eigen1], the association between infectivity and aggregated PrP, the linear appearance of the fibrils and to take into account fundamental processes of an *in vivo* replication (i.e. fibrils splitting), all while remaining relatively mathematically tractable. Moreover, its dynamical behavior has been extensively studied [@pcbi.1000420-Greer1],[@pcbi.1000420-Rubenstein1], and experimental measurements were used in [@pcbi.1000420-Masel2] to provide an estimation of the full set of parameters for a particular prion strain. The model has three state variables (Eq. 10) describing the amount of monomer (), polymer () and the mass of polymer (), and it involves 6 parameters (see [Table 1](#pcbi-1000420-t001){ref-type="table"}). We reproduce here only the features essential to discuss the strain dependence of its parameters; the details are covered in [Materials and Methods](#s4){ref-type="sec"}.

10.1371/journal.pcbi.1000420.t001

###### Model symbols.

![](pcbi.1000420.t001){#pcbi-1000420-t001-1}

  --------------------------- ---------------------------- --
  **Model state variables**        amount of monomer       
                                   amount of polymer       
                                    mass of polymer        
  **Model parameters**                nucleus size         
                               rate of monomer production  
                                  rate of degradation      
                                  rate of aggregation      
                                   rate of clearance       
                                    rate of breakage       
  --------------------------- ---------------------------- --

Description of all state variables and parameters.

In [@pcbi.1000420-Masel1] it has been shown that for any prion strain two parameters, the rate of growth () and the reproductive ratio (), can be estimated from experimental data. The former (Eq. 2) represents the exponential growth of the number of infectious particles. The latter (Eq. 3) is defined as the average number of prion fibrils that a single infectious particle can give rise to, before splitting into fibrils smaller than a critical size or being degraded. In other words, represents the ability of the fibrils to survive to critical breakage and degradation events. The equations for the and parameters obtained from the kinetic model of [@pcbi.1000420-Masel1] can be reparametrized in terms of the mean length of the fibrils obtaining:

In order to estimate from experimental measures both parameters ( and ) certain assumptions are necessary (see [Materials and Methods](#s4){ref-type="sec"} for full details). An estimation of and from *in vivo* experiments and for different prion strains characterized by different values of stability against denaturation () is listed in [Table 2](#pcbi-1000420-t002){ref-type="table"}. The dataset currently available is limited (as not many prion strains can be fully characterized) and many error sources are potentially affecting the estimation of the parameters. Nevertheless, [Figure 1](#pcbi-1000420-g001){ref-type="fig"} shows the existence of a negative trend between these two empirical parameters (Pearson correlation = −0.91, p-value = 0.01). If we now turn to the kinetic model and look at the corresponding expressions (Eq. 2, 3) the interesting question is whether such a behavior is predicted by the model itself, and is explainable in terms of some of its parameters, in a way that is both mathematically and biologically plausible. Otherwise stated, we investigate which, if any, among the model parameters best describe the strain variability. The critical size of the nucleus (parameter in the model) plays a marginal role in our analysis and is likely to be a fixed integer, in between 2 and 4, across different strains [@pcbi.1000420-Govaerts1]. Even though it has been argued that a hexamer is the minimum infectious unit [@pcbi.1000420-Nakamura1], it can be shown that the model-based conclusions are not conditioned by the value of . In addition is clearly independent of the prion strains, so we remain with three possible choices: , and . From Eq. 1, increasing means incrementing and this affects and in a similar manner, so that this parameter alone cannot explain the inverse relationship derived in [Figure 1](#pcbi-1000420-g001){ref-type="fig"}. The same can be said for and which, if increased/decreased, would induce changes of equal sign in and . Different conclusions can be drawn when considering as the only strain-varying parameter. This dependence becomes clearer assuming that fibrils cannot be degraded in the exponential phase (, identical results can be obtained supposing that the degradation of the fibrils scales as the fibrils breakage rate, , see [Text S2](#pcbi.1000420.s004){ref-type="supplementary-material"}). Such assumption leads to the following expressions:

10.1371/journal.pcbi.1000420.t002

###### Estimated empirical parameters for different prion strains.
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  Prion strain                                                                           
  ------------------ -------------------------------- ---------------------------------- ---------------------------
  139A                              --                 0.05 [@pcbi.1000420-Somerville1]               2
  ME7                               3                               0.024                            2.9
  BSE                 3.48 [@pcbi.1000420-Castilla1]                0.015                            2.8
  Sc237                2 [@pcbi.1000420-Prusiner2]      0.11 [@pcbi.1000420-Prusiner3]               1.6
  RML                   2.1 [@pcbi.1000420-Masel2]      0.18 [@pcbi.1000420-Thackray1]               1.7
  MK4985                           3.9                                --                             3.8
  vCJD                              --                 0.07 [@pcbi.1000420-Manuelidis1]   1.85 [@pcbi.1000420-Lau1]
  Fukuoka-1 CJD        3 [@pcbi.1000420-Prusiner4]     0.03 [@pcbi.1000420-Sakaguchi1]               --
  Chandler Scrapie       2 [@pcbi.1000420-Masel1]        0.17 [@pcbi.1000420-Masel1]                 2.2
  301 V                             --                   0.07 [@pcbi.1000420-Taylor1]                2.2

The estimated values for the reproductive ratio (Eq. 11), rate of growth and stability against denaturation for different prion strains are shown. One of them (MK4985) is a synthetic prion strain that requires a high concentration of Gdn-HCL to denature 50% of the pathogenic protein. Whenever no reference is shown, [@pcbi.1000420-Legname1] is used.

![Relationships between the empirical parameters and .\
The reproductive ratio is plotted against the rate of growth. The downward trend is not well described by the linear model with negative angular coefficient () and an intercept () (dotted blue line). In addition, the model prediction with fixed (dashed-dot black line) fails to precisely represent the data, even if it provides a more reasonable relationship (notice that high stable prions, such as MK4985, would always be associated to positive values). Introducing one more degree of freedom (exponent ) yields a higher value (red line, ). This result corresponds to a prediction of . In addition, we tested a further simplified model version (where is considered to be much smaller than ) according to which (i.e. , shown in green). Similar conclusions could be drawn.](pcbi.1000420.g001){#pcbi-1000420-g001}

If we keep into account only the dependence from , then Eq. 4 and Eq. 5 can be simplified to

From these simplified formulas it is clear that an increase in the frangibility of the fibers (i.e., in ) produces an increment of (Eq. 7) and a decrement of (Eq. 8) in agreement with the trend in [Figure 1](#pcbi-1000420-g001){ref-type="fig"}. Therefore, from the model we expect to give the best fitting result. As a matter of fact, this relationship (black dash-dotted line in [Figure 1](#pcbi-1000420-g001){ref-type="fig"}) does not provide the optimal fit, although it reproduces the qualitative observed behavior (). The fittings of [Figure 1](#pcbi-1000420-g001){ref-type="fig"} (see [Table 3](#pcbi-1000420-t003){ref-type="table"}) suggest that, approximately, (red line) implying that we are observing proportional to and to (see [Materials and Methods](#s4){ref-type="sec"}, Eq. 12). This means that the estimated exponents for are somewhat different from the expected values of () predicted in Eq. 7 and 8. In order to improve the model prediction, we introduce a strain-dependence on a second parameter. The simplest solution suggested by the model for this scope (deducible from Eq. 4 and 5) points to the aggregation rate . By linking to , we are still left with a one-parameter family of models describing the strain-dependence. In doing so, we obtain the estimate (see again [Materials and Methods](#s4){ref-type="sec"}, Eq. 13). This correction yields and , this time respecting the predictions of Eq. 4 and 5. Therefore, on the one hand we can show that at a qualitative level is the only parameter that alone can explain the inverse relationship between and . On the other hand, the variation of by itself is not able to quantitatively describe the experimental data in a precise way. An additional correction, obtained relating to , leads to a substantially improved fitting. Apart from Eq. 4 and 5, our choice of alongside as strain-dependent parameter is suggested by the structure of the model of Eq. 10, in which, of all parameters, those describing the kinetics of fibril aggregation/breakage are the most likely to vary across strains. Both the fitting and the model structure suggest an interplay between and , with partially balancing the effect of .

10.1371/journal.pcbi.1000420.t003

###### Fitted values for the curves in [Figure 1](#pcbi-1000420-g001){ref-type="fig"} and [Figure 2](#pcbi-1000420-g002){ref-type="fig"}.
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  Relationship    Estimated parameters   R-square   p.value
  -------------- ---------------------- ---------- ----------
  **vs**                                 **0.97**  
                                           0.83      0.0109
                                           0.96    
                                           0.04    
                                          *0.97*   
  **vs**                                 **0.69**   **0.01**
                                           0.41      0.0848
                                           0.67      0.0123
                                           0.53      0.0104
                                          *0.7*     *0.0093*
  **vs**                                   0.87      0.0069

The linear and non linear relationships, with and without the intercept, for and are reported here. These models are fitted to the experimental measurements listed in [Table 2](#pcbi-1000420-t002){ref-type="table"}. For each model the fitting parameters, and the correlation p-value are reported. When and are related to , the non linear model with a fixed intercept and a free exponent (i.e. ) is associated with the best fitting results (bold). By adding one more free parameter (i.e. ) we do not get essentially any improvement (italic). The estimated value for , without any simplification, implies , and (see [Materials and Methods](#s4){ref-type="sec"}). A direct proportionality is observed also for .

In the following, we will describe how the previous results can be extended to the stability to denaturation of the prion strains, providing experimental observations in support of our claims. From [Figure 2A](#pcbi-1000420-g002){ref-type="fig"} a direct linear proportionality between and is inferred. Therefore, combining the fitting between and and and , a similar inverse relationship (see [Figure 2B](#pcbi-1000420-g002){ref-type="fig"}) relates and (see [Table 3](#pcbi-1000420-t003){ref-type="table"}). A point of note is that a linear model (i.e., ) is not only associated to a low coefficient of determination but is also implausible, as it predicts negative values of in correspondence of very stable prion strains (such as MK4985, see [Table 4](#pcbi-1000420-t004){ref-type="table"}). Owing to the linear proportionality () of [Figure 2A](#pcbi-1000420-g002){ref-type="fig"}, the inferred functional dependencies from extend to (i.e., ). This result, in light of the experimental observations in [@pcbi.1000420-Tanaka1], contributes to validate the results of the kinetic model and provides us with a simple practical tool to interpret prion strain stability. As a matter of fact, the experimental data in [@pcbi.1000420-Tanaka1] report a relationship between the chemical stability of yeast prion strains and their structural properties, hence reinforcing our conclusions. In particular, the frangibility of different Sup35NM amyloid conformations was measured and shown to be consistent with an increase in sensitivity to denaturants and proteases. Thus, confirming the main role of the breakage rate, as predicted here by the model. Furthermore, the authors observed also a variation in the aggregation rate (parameter in the model), which was however overcome by the stronger effect of the division rate; an additional observation in agreement with our results, where the best match with the experimental data is obtained for a variation of that only partially compensates for that of . The importance of breakage events for the *in vivo* prion propagation is also underlined in [@pcbi.1000420-Cox1], where the authors observed that membrane-anchored PrP is necessary for the exponential growth of prion aggregates. In transgenic mice, expressing anchorless prion protein inoculated with different prion strains, the aggregates seem to grow quadratically in time [@pcbi.1000420-Chesebro1]. This feature is explainable by a linear aggregation model (i.e setting equal to 0). Moreover, in [@pcbi.1000420-Chesebro1], different prion strains show a common inability to induce the disease. The absence of fibrils disruption can prevent the formation of oligomeric species, thus hiding the difference between prion strains. Our model-based analysis suggests that an experiment monitoring the propagation of prion strains lacking the GPI anchor would be useful to characterize in more depth the strain phenomenon.

![Relationships between , and .\
In (A) and (B) the stability against denaturation is plotted against the reproductive ratio and the rate of growth. A direct proportionality links to . As expected, an inverse proportionality emerges between and , reinforcing the previous results.](pcbi.1000420.g002){#pcbi-1000420-g002}

10.1371/journal.pcbi.1000420.t004

###### Estimated model parameter for different prion strains.

![](pcbi.1000420.t004){#pcbi-1000420-t004-4}

  Prion strain                                                                                      
  -------------------- ------------------------------ ------------ ---------- ---------- ---------- ----------
  139A                               2                   0.0352      0.033      0.0665     0.1131      7.39
  ME7                               2.9                  0.0036      0.015      0.0316     0.0538      9.36
  BSE                               2.8                  0.0043      0.017      0.0339     0.0577      9.14
  Sc237                             1.6                  0.2132      0.051      0.1039     0.1767      6.51
  **RML**                         **1.7**              **0.1241**   **0.02**   **0.06**   **0.15**   **6.73**
  MK4985                            3.8                  0.0009      0.009      0.018      0.031      11.33
  vCJD                              1.85                 0.0625      0.038      0.078      0.132       7.06
  Chandler Scrapie                  2.2                  0.0184      0.027      0.055      0.093       7.83
  301 V                             2.2                  0.0184      0.027      0.055      0.093       7.83
  RecMoPrP (89--230)    5.1 [@pcbi.1000420-Legname1]     0.0002      0.005      0.010      0.017      14.19

Using Eq. 9 and assuming equal to 3, the breakage rate can be estimated (second column, ) from G. In [@pcbi.1000420-Masel2] the authors provide for the RML strain (bold) a lower and an upper bound for (0.98 and 3.4 prion/day) in addition to the best estimate (). The fitting obtained in [Figure 2A](#pcbi-1000420-g002){ref-type="fig"} is used here to infer from . We can fix to the values reported in [@pcbi.1000420-Masel2] for different strains and estimate (as the only varying parameter) from Eq. 11. Comparing the values estimated in [@pcbi.1000420-Masel2] and our extrapolated values, we see contained differences (see [Figure S1](#pcbi.1000420.s001){ref-type="supplementary-material"}). This result shows that is the main parameter explaining strain kinetic variability. A remarkable advantage of this method is that it requires only a single rather simple experimental measurement (i.e. resistance to guanidine denaturation) in order to predict the replication dynamics of a particular strain.

In the last part of the Section, we investigate how the prion stability () is reflected in the mean length of the fibrils (). Combining the fitting of [Figure 2](#pcbi-1000420-g002){ref-type="fig"} with Eq. 6, (and consequently , from Eq. 1) can be inferred directly from and :In [Table 4](#pcbi-1000420-t004){ref-type="table"}, we compare the approach of Eq. 9 with the results obtained in [@pcbi.1000420-Masel2], where the authors give a complete estimation (including a range of uncertainty) of all the parameters for the RML prion strain (, highlighted in bold in [Table 4](#pcbi-1000420-t004){ref-type="table"}). The comparison between these two approaches shows that the predictions obtained through Eq. 9 are similar to the values reported in [@pcbi.1000420-Masel2] for the RML strain. In addition, we can compare the values of for the strains inferred from Eq. 9, with the ones computed using Eq. 11 and then imposing equal to the values of [@pcbi.1000420-Masel2] for the RML strain (see [Figure S1](#pcbi.1000420.s001){ref-type="supplementary-material"}). Our predictions are approximately within the range of values computed considering constant among strains. This result reinforces the major role of in explaining strain variability. Owing to the fact that is now strain-dependent (), we can also predict the mean length of the fibrils (Eq. 1) for each considered strain (see [Table 4](#pcbi-1000420-t004){ref-type="table"}, ). For instance the mean length of the fibrils population for two prion strains with different stabilities (e.g. RecMoPrP (89--230) and Sc237) can be compared. For the unstable prion strain (Sc237) this is approximately 7 monomer units, while for the stable prion strain (RecMoPrP (89--230)) it is approximately 14 monomer units. This theoretical approach provides a valuable method to simplify the model characterization. Furthermore, it contributes to understanding the properties associated to prion strains with different stability against guanidine denaturation.

Discussion {#s3}
==========

While it is reasonable that the parameters of the kinetic model might all be affected by strain specificities (i.e. stability against denaturation), the dominant contribution seems to be due to the susceptibility to frangibility (i.e. ), with only a minor correction due to . The inverse relationship between and shown in [Figure 1](#pcbi-1000420-g001){ref-type="fig"} is the main argument in the identification of as the key physical aspect differentiating prion strains. In addition, is suggested as the most plausible and parsimonious correcting factor, in order to improve the data fitting.

Several aspects can influence the estimation of the parameters and the model predictions. For example, the uncertainty affecting the estimation of and (respectively inferred from an exponential curve and from a ratio of exponentials); or the possibility that the breakage rate is not equal across all the different polymer lengths (e.g. mechanical stress can differently affects longer fibers); or even the impact of the mouse age on the model parameters (affecting e.g. the production rate). In spite of these (and potentially many other) disregarded aspects characterizing an *in vivo* system, this simple model is able to capture and explain the observed data dependencies through arguments supported by multiple independent experimental observations. Our analysis reveals that stable prion strains can be characterized by a "stronger" aggregated structure which is less prone to breakage events. This will further imply a longer mean length of the fibrils. Instead, unstable prion strains are subject to a higher fragmentation rate. The role of is essentially to partially balance the increased breakage and is coherent with the experimental observations in yeast. Furthermore, the increased number of catalytic sites may be also responsible for the shorter incubation time.

As already mentioned, such phenomenon was observed in yeast prions [@pcbi.1000420-Osherovich1]. The yeast prion proteins, although fundamentally different from the mammalian prion proteins, show the same ability to convert into aggregated forms, propagate and be infectious. This simpler unicellular system is a valuable model as it enables a deeper analysis of the fibril formation process [@pcbi.1000420-Toyama1], not possible to the same extent in higher organisms.

The framework proposed allows for a model-based analysis of these properties in mammalian prions *in vivo*. In the context of mammals, our results are consistent with [@pcbi.1000420-Sun1], where fibrils with different conformational stability are generated *in vitro* from full length mammalian PrP. In that paper, the authors relate the stability to the size of the smallest possible fibrillar fragment without taking into account the kinetics of the replication (reproducing the *in vivo* behavior). We draw similar conclusions from a different point of view. As a matter of fact, we investigate the dynamic evolution of prion propagation in a multicellular *in vivo* system, in which molecular and cellular mechanisms are present as well. Our model-based conclusions provide further evidence that *in vitro* systems and yeast prion propagation mechanisms can be transposed in mammals. Moreover, linking the strain phenomena to dynamical features leads to a characterization of the evolution of the length of the fibrils *in vivo*.

We can, in fact, speculate (in agreement with [@pcbi.1000420-Petkova1]) that stable prion strains exhibit a proliferation of longer fibrils that, upon splitting, still manifest the same stability properties ([Figure 3](#pcbi-1000420-g003){ref-type="fig"}), giving rise to a preferential proliferation of relatively long fibrils with a low toxic effect. On the other hand, less stable prion strains tend to form shorter fibrils, to proliferate faster and to be more neurotoxic.

![Kinetic model and prion pathways.\
The cartoon describes the pathways of kinetic replication of two prion strains with a different stability against denaturation: a stable one (high ) and an unstable one (low ) are drawn. These act as templates bringing the same cellular prion protein (triangle) to the two different strain conformations ( ▴→ ▪, ♦). The model assumes that the aggregation of monomers to polymers produces a very fast change of conformation and that this aggregation is unfavorable below a critical size (), which is assumed to be independent of the prion strain in our model. The experimental data suggest that stable prions are characterized by a higher and a corresponding lower . In the model, this is translated into strain-specificity of the rates of breakage and of aggregation (which are both lower for stable prions). This implies that stable fibrils are longer and prefer to proliferate while maintaining themselves as fibrils larger than the nucleus size (pathway on the left). On the contrary, unstable prions are more frangible (i.e. more sensitive to breakage), implying a shorter mean length. This means that breakage events are more likely to be associated with the formation of very short fibrils, even under the critical size. The increase in the aggregation rate is not enough to avoid an increased growth in the number of fibrils. We can therefore hypothesize that an apoptotic pathway is most likely for these last strains (pathway on the right). These conclusions are in agreement with the working hypothesis of oligomer toxicity [@pcbi.1000420-Simoneau1].](pcbi.1000420.g003){#pcbi-1000420-g003}

It is worth noting the connection with [@pcbi.1000420-Pellarin1], where the kinetics of aggregation of amyloid peptides is studied by means of coarse-grained molecular dynamics. The authors showed how the relative stability of -prone states of a polypeptide can influence the pathway of aggregation. Their results suggest that the -stable amyloids follow an aggregation pathway without intermediates, while -unstable amyloids seem to involve on-pathway oligomers.

The characterization of prion strains in terms of polymer mean size is *per se* a significant observation. It provides a new possible explanation of the observation that stability is correlated with lesion profiles and vacuolation areas. Several hypotheses have been made, such as the existence of a co-factor that supports the conversion of distinct prion strains in precise brain regions. Here, another possibility emerges: the increased size associated to stable prions can decrease their ability to diffuse, and can circumscribe them to small brain regions. On the contrary, oligomers can spread around the brain more easily, causing a more homogeneous damage.

In conclusion, we show that linking the conformational stability property of prions, acquired during *in vivo* propagation in mammals, to their replication kinetic properties is achievable through a rather simple model. For a wide range of parameters, the model predicts that a higher breakage rate implies shorter and shorter incubation time (in [Figure S2](#pcbi.1000420.s002){ref-type="supplementary-material"} two simulations are compared). Our model-based approach suggests that the amount of information that can be extrapolated from the knowledge of goes beyond the expected incubation time.

Materials and Methods {#s4}
=====================

Kinetic model {#s4a}
-------------

*In vitro* prion propagation is characterized phenomenologically by the following properties: (i) a critical concentration threshold below which fibrils cannot form; (ii) a delay before their propagation (which can be eliminated by the addition of seeds of preformed fibrils); (iii) a direct proportionality between the initial rate of fiber growth and the monomer concentration [@pcbi.1000420-Collins1]. The overall behavior resembles a sigmoidal growth curve [@pcbi.1000420-Stohr1]: an exponential growth of infectious particles followed by a plateau. The simplest description of the underlying observed mechanism of protein aggregation consists of a slow continuous nucleation followed by a fast autocatalytic growth. Therefore a simple two-step model is able to reproduce the dynamics of the *in vitro* prion propagation [@pcbi.1000420-Morris1]. An *in vivo* prion propagation model should explain the fact that the spontaneous prion-induced disease is rare but progresses inevitably after infection, that the incubation period is long and followed by a brief fatal clinical disease and that prions undergo several molecular processes within the cell (e.g. fibrils breakage, degradation, endogenous production). The model derived in [@pcbi.1000420-Masel1] is obtained as a closed form of an infinite set of differential equations describing the variation in time of the monomer and fibrils of each possible length (from to ). The biological mechanisms taken into account are the lengthening at the fiber end by the addition of monomers, the degradation of polymers, and their splitting into smaller polymers. Only if several monomeric molecules are mounted into a highly ordered seed, can further monomeric be recruited and form amyloid aggregates. If, after the breakage, the fibril has a length under the critical size, it degrades instantaneously into normal monomers. The model in Eq. 10 has three state variables, describing the amount of monomer (), polymer () and the mass of polymer (), and it comprises of 6 independent parameters: nucleus size (), rates of production (), degradation (), aggregation (), clearance () and breakage ():

The assumption that is negligible, made in in order to simplify the parameters equations, changes the qualitative behavior of the model, that no longer has two stable steady states but only one, which is unstable. This means that the exponential growth will never reach a plateau. As mentioned in the text, this does not affect our previous considerations, especially in light of the fact that *in vivo* death occurs during the exponential growth phase (see also the [Text S2](#pcbi.1000420.s004){ref-type="supplementary-material"} for similar conclusions on the full model).

Measuring the parameters and {#s4b}
----------------------------

In this section we summarize the procedures mentioned in [@pcbi.1000420-Masel1] and adopted here to derive a measure for and . The assumptions deemed, in order to measure and from the observed effect of different levels of PrP expression and inoculum dosage, are as follows:

1.  i) The linear relationship relating the incubation time to the inoculum log dilution reflects the exponential growth of the infectious units.

2.  ii) The only parameter that varies between two transgenic mice with an altered level of expression is considered to be the production rate ().

3.  iii) The termination stage (animal death) occurs during the exponential growth phase.

4.  iv) The level of in the brain at the termination stage can be considered to be the same in all experiments.

Of all assumptions, the last one is the most important. It is considered valid also for transgenic mice expressing different quantities of cellular prion protein. Currently there is wide debate about the cause of cell death in prion neurodegeneration. From knockout mutants, it seems that loss of function is not sufficient to cause cell death. What has been observed is that the conversion of to the isoform has a key role in the disease. In spite of their apparent low neurotoxic effect [@pcbi.1000420-Chesebro1], fibrils have been proven to be the main ingredient in catalyzing variations of protein conformation [@pcbi.1000420-Jones1]. Therefore, it is reasonable to assume that even if toxicity is not directly associated to fibrils aggregates, it has to be closely related to their amount, implying that a critical concentration of is required to provoke cell death. The current working hypothesis is that oligomeric species are the most infectious [@pcbi.1000420-Silveira1] and a substantial body of evidence suggests that they are also highly cytotoxic [@pcbi.1000420-Bucciantini1]. According to the previous observations, a possible explanation is that an equal mass of prion fibrils with smaller mean size provides a larger number of active sites for catalysis, hence inducing a higher lethality.

In order to extrapolate a measure for we follow the method described in [@pcbi.1000420-Masel1] based on relating the incubation time to the inoculum dose and implying an exponential growth in the number of infectious particles. Taking advantage of these data (e.g. incubation time inoculum dosage), we can infer the parameter just by fitting an exponential growth curve. More precisely, before inoculation of prions, PrP () can be considered at steady state (). After inoculation, it is reasonable to assume that it remains almost constant for a while. According to the model equations, the steady state of the mean polymers distribution length ( in Eq. 1), is typically reached before the exponential phase. Immediately after reaching , the polymer amount () and the polymer mass () start to grow exponentially. Thus, is defined as the dominant mode of this exponential growth (i.e., ) (Eq. 2).

To have an indirect measurement of , the inverse relationship between incubation time and the PrP expression is exploited. We take into account the previous assumptions reporting that the number of infectious units in two inoculated mice expressing different level of PrP (, ) at the times of death (, ) can be considered almost equal. Thus imposing we can derive :where and .

For a more detailed description see Appendix of [@pcbi.1000420-Masel1]. It is worth noticing that the incubation times listed in [@pcbi.1000420-Legname1] are not the same as those used to estimate (see [Text S1](#pcbi.1000420.s003){ref-type="supplementary-material"} for more details).

Computing the and exponents {#s4c}
---------------------------

Rather that using Eq. 7 and 8, the exponents and such that , can be computed from the fitted curve in [Figure 1](#pcbi-1000420-g001){ref-type="fig"}. We approximate the numerical value 0.38 of [Table 3](#pcbi-1000420-t003){ref-type="table"} with 0.4 (i.e. ). From the above expressions, , which yields , i.e., or . Examples of values on this line are:From Eq. 6 it is clear that the only admissible pair of values isIf, following Eq. 4 and 5, we add the extra functional dependence of from as , we can look for a value of that satisfies simultaneously yielding:
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